Cargando…
Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
Selective serotonin reuptake inhibitors (SSRIs) are currently the treatment of choice in depression and constitute major portion of prescription in depressive patients. The role of serotonin receptors in bone is emerging, raising certain questions regarding the effect of blockade of serotonin reupta...
Autores principales: | Wadhwa, Ravisha, Kumar, Manoj, Talegaonkar, Sushama, Vohora, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Osteoporosis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372777/ https://www.ncbi.nlm.nih.gov/pubmed/30775508 http://dx.doi.org/10.1016/j.afos.2017.05.002 |
Ejemplares similares
-
Data of aromatase inhibitors alone and in combination with raloxifene on microarchitecture of lumbar vertebrae and strength test in femoral diaphysis of VCD treated ovotoxic mice
por: Kalam, Abul, et al.
Publicado: (2016) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
por: Srivastava, Ankit, et al.
Publicado: (2019) -
Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996) -
Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
por: Nguyen, Thanh Thanh L., et al.
Publicado: (2021)